Application no. and date | 15151452.8 (espacenet) (Federated) (European Patent Register), 20091020 | Patent/reg. no. and date | DK/EP 2937418, 20171018 | Publication date | 20151028 | Priority no. and date | US 106956 P, 20081020, US 115738 P, 20081118, US 156670 P, 20090302, US 185545 P, 20090609, US 242783 P, 20090915, US 244794 P, 20090922 | EP pub. no. and date |
EP 2937418 20151028 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US | Applicant ref. no. | ALN ALN-078EPD1 | Inventor | HINKLE, Gregory, C/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor
Cambridge, MA 02142, US, CHEN, Qingmin, C/o Alnylam Pharmaceuticals Inc. 300Third Street Third Floor
Cambridge, MA 02142, US, ALVAREZ, Rene, C/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor
Cambridge, MA 02142, US, MILSTEIN, Stuart, C/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor
Cambridge, MA 02142, US, Sah, Dinah Wen-yee, c/o Alnylam Pharmaceuticals Inc. 300 Third Street Third Floor
Cambridge, MA 02142, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/713 (2006.01) , C12N 15/11 (2006.01) , C12N 15/113 (2010.01) | Title | Sammensætninger og fremgangsmåder til inhibering af ekspression af transthyretin | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2019 00005 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|